These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2952570)

  • 1. [Immunopharmacological actions of lumin (II): Effect of lumin administration in NZB X NZW (B/W) F1 mice].
    Sasaki Y; Nagai N; Okimura T
    Nihon Yakurigaku Zasshi; 1987 Jan; 89(1):9-13. PubMed ID: 2952570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
    McMurray RW; Elbourne KB; Lagoo A; Lal S
    J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunopharmacological actions of lumin (I): Anti-allergic actions of lumin].
    Sasaki Y; Nagai N; Okimura T; Yamamoto I
    Nihon Yakurigaku Zasshi; 1987 Jan; 89(1):1-7. PubMed ID: 3570101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a nucleoside-specific suppressor T cell line from SLE prone (NZB/NZW)F1 mice.
    Naiki M; Imai Y; Osawa T
    J Immunol; 1985 Aug; 135(2):1080-5. PubMed ID: 2409137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
    Zhang M; Yu G; Chan B; Pearson JT; Rathanaswami P; Delaney J; Ching Lim A; Babcook J; Hsu H; Gavin MA
    Arthritis Rheumatol; 2015 Oct; 67(10):2723-31. PubMed ID: 26097207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel function of B lymphocytes from normal mice to suppress autoimmunity in (NZB x NZW)F1 mice.
    Ono S; Shao D; Yamada S; Yang Y; Yamashita M; Hamaoka T
    Immunology; 2000 May; 100(1):99-109. PubMed ID: 10809965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW x BXSB)F1 hybrid mice.
    Cerny A; Starobinski M; Hügin AW; Sutter S; Zinkernagel RM; Izui S
    J Immunol; 1987 Jun; 138(12):4222-8. PubMed ID: 3495583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB x NZW) F1 mice from lupus-like disease.
    Liu SD; Lee S; La Cava A; Motran CC; Hahn BH; Miceli MC
    Lupus; 2011 Apr; 20(5):473-84. PubMed ID: 21335401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice.
    Foell J; Strahotin S; O'Neil SP; McCausland MM; Suwyn C; Haber M; Chander PN; Bapat AS; Yan XJ; Chiorazzi N; Hoffmann MK; Mittler RS
    J Clin Invest; 2003 May; 111(10):1505-18. PubMed ID: 12750400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB/W murine model of systemic lupus erythematosus.
    Austin HA; Patel AD; Cadena CA; Boumpas DT; Balow JE
    J Rheumatol; 1997 Jan; 24(1):61-8. PubMed ID: 9002012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell tolerance induction is normal in the (NZB x NZW)F1 murine model of systemic lupus erythematosus.
    Wither J; Vukusic B
    Immunology; 2000 Mar; 99(3):345-51. PubMed ID: 10712663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell activation and cellular cooperation in autoimmune NZB/NZW F hybrid mice.
    Roder JC; Bell DA; Singhal SK
    J Immunol; 1975 Aug; 115(2):466-72. PubMed ID: 1097516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
    Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
    Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW)F1 mouse model of systemic lupus erythematosus.
    Ebling FM; Tsao BP; Singh RR; Sercarz E; Hahn BH
    Arthritis Rheum; 1993 Mar; 36(3):355-64. PubMed ID: 7680861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent responsiveness to interleukin-6 in B lymphocytes from a systemic lupus erythematosus-prone (NZB x NZW)F1 hybrid.
    Alarcón-Riquelme ME; Möller G; Fernández C
    Clin Immunol Immunopathol; 1992 Mar; 62(3):264-9. PubMed ID: 1541052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice.
    Theofilopoulos AN; Shawler DL; Eisenberg RA; Dixon FJ
    J Exp Med; 1980 Feb; 151(2):446-66. PubMed ID: 6444324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.
    Carlsten H; Holmdahl R; Tarkowski A
    Immunology; 1991 Jun; 73(2):186-90. PubMed ID: 2071164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice.
    Kotzin BL; Palmer E
    J Exp Med; 1987 May; 165(5):1237-51. PubMed ID: 3494806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
    Okudaira H; Terada E; Okudaira K
    Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of oral tolerance in (NZB X NZW)F1 mice is antigen specific and appears to parallel antibody patterns in human systemic lupus erythematosus (SLE).
    Carr RI; Tilley D; Forsyth S; Etheridge P; Sadi D
    Clin Immunol Immunopathol; 1987 Mar; 42(3):298-310. PubMed ID: 2951041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.